Literature DB >> 10783266

The expanded human kallikrein gene family: locus characterization and molecular cloning of a new member, KLK-L3 (KLK9).

G M Yousef1, E P Diamandis.   

Abstract

In rodents, kallikreins are encoded by a large multigene family but in humans, only three kallikrein genes were thought to exist. Based on the homology between the human and the rodent kallikrein loci, we defined a 300-kb human kallikrein gene region on chromosome 19q13. 3-q13.4. By using linear sequence information, restriction analysis, PCR, and blotting techniques, we were able to construct the first detailed map of the human kallikrein gene locus. Comparative analysis of genes located in this area enabled us to expand the human kallikrein multigene family with some recently identified serine proteases and establish common structural features. We further identified a new kallikrein-like gene, named kallikrein-like gene 3 (KLK-L3; HGMW-approved symbol KLK9). We describe the structural characterization of the KLK-L3 gene, together with its precise chromosomal localization in relation to other kallikreins and its tissue expression pattern and hormonal regulation. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10783266     DOI: 10.1006/geno.2000.6159

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  12 in total

1.  VAMP8/endobrevin as a general vesicular SNARE for regulated exocytosis of the exocrine system.

Authors:  Cheng-Chun Wang; Hong Shi; Ke Guo; Chee Peng Ng; Jie Li; Bin Qi Gan; Hwee Chien Liew; Jukka Leinonen; Hannu Rajaniemi; Zhi Hong Zhou; Qi Zeng; Wanjin Hong
Journal:  Mol Biol Cell       Date:  2007-01-10       Impact factor: 4.138

2.  A synthetic tissue kallikrein inhibitor suppresses cancer cell invasiveness.

Authors:  W C Wolf; D M Evans; L Chao; J Chao
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

3.  Detection of tissue kallikrein and kinin B1 and B2 receptor mRNAs in human brain by in situ RT-PCR.

Authors:  R Mahabeer; S Naidoo; D M Raidoo
Journal:  Metab Brain Dis       Date:  2000-12       Impact factor: 3.584

4.  Kallikrein-related peptidase-8 (KLK8) is an active serine protease in human epidermis and sweat and is involved in a skin barrier proteolytic cascade.

Authors:  Azza Eissa; Vanessa Amodeo; Christopher R Smith; Eleftherios P Diamandis
Journal:  J Biol Chem       Date:  2010-10-12       Impact factor: 5.157

5.  Blocking serine protease activity prevents semenogelin degradation leading to hyperviscous semen in humans.

Authors:  Prashanth Anamthathmakula; Jeffery A Erickson; Wipawee Winuthayanon
Journal:  Biol Reprod       Date:  2022-05-17       Impact factor: 4.161

Review 6.  Functions of KLK4 and MMP-20 in dental enamel formation.

Authors:  Yuhe Lu; Petros Papagerakis; Yasuo Yamakoshi; Jan C-C Hu; John D Bartlett; James P Simmer
Journal:  Biol Chem       Date:  2008-06       Impact factor: 3.915

7.  A completed KLK activome profile: investigation of activation profiles of KLK9, 10, and 15.

Authors:  Hyesook Yoon; Sachiko I Blaber; Mekdes Debela; Peter Goettig; Isobel A Scarisbrick; Michael Blaber
Journal:  Biol Chem       Date:  2009-04       Impact factor: 3.915

8.  Gene expression changes during HPV-mediated carcinogenesis: a comparison between an in vitro cell model and cervical cancer.

Authors:  Fang Wan; Xijiang Miao; Iram Quraishi; Valerie Kennedy; Kim E Creek; Lucia Pirisi
Journal:  Int J Cancer       Date:  2008-07-01       Impact factor: 7.396

9.  Kallikrein gene downregulation in breast cancer.

Authors:  G M Yousef; G M Yacoub; M-E Polymeris; C Popalis; A Soosaipillai; E P Diamandis
Journal:  Br J Cancer       Date:  2004-01-12       Impact factor: 7.640

10.  Increased Klk9 Urinary Excretion Is Associated to Hypertension-Induced Cardiovascular Damage and Renal Alterations.

Authors:  Ana M Blázquez-Medela; Omar García-Sánchez; Yaremi Quirós; Victor Blanco-Gozalo; Laura Prieto-García; Sandra M Sancho-Martínez; Miguel Romero; Juan M Duarte; Francisco J López-Hernández; José M López-Novoa; Carlos Martínez-Salgado
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.